“Eat Move Live” program, developed for Proactive MD patients to reduce diabetes risk, recognized by CDC

Ads

You May Also Like

Delcath Announces Third Quarter 2017 Financial Results

NEW YORK, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional ...

AzurRx Provides Update on MS1819 Phase II Trial

Initial patient experience shows no safety issues MS1819 appears active, as demonstrated by CFA ...